Related references
Note: Only part of the references are listed.Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress
Xiangyan Jiang et al.
GASTROENTEROLOGY (2023)
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
Emeric Limagne et al.
CANCER CELL (2022)
TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer
Shuang Shang et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
Xiaozhen Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Cancer-associated fibroblasts in the single-cell era
Dor Lavie et al.
NATURE CANCER (2022)
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment
Chiara Falcomata et al.
NATURE CANCER (2022)
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer
Jin Huang et al.
GUT (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice
Ivana Peran et al.
GASTROENTEROLOGY (2021)
EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1
Brenna Weadick et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
Yang Chen et al.
CANCER CELL (2021)
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Kazuhiro Koikawa et al.
CELL (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1
Xiaozhen Zhang et al.
NATURE COMMUNICATIONS (2021)
CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions
Veethika Pandey et al.
ELIFE (2021)
CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways
Xiaona Chen et al.
FRONTIERS IN ONCOLOGY (2021)
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities
Won Jin Ho et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions
Min Tang et al.
CELL RESEARCH (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets
Martin C. Whittle et al.
GASTROENTEROLOGY (2019)
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Ludmila Danilova et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer
Tsz-Lun Yeung et al.
CLINICAL CANCER RESEARCH (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
Praneeth R. Kuninty et al.
SCIENCE ADVANCES (2019)
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E. Hessmann et al.
GUT (2018)
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance
Cecilia S. Leung et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
Chenlu Zhang et al.
BMC CANCER (2018)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
Christopher C. DuFort et al.
BIOPHYSICAL JOURNAL (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
Patricia Marti et al.
HEPATOLOGY (2015)
Compression of Pancreatic Tumor Blood Vessels by Hyaluronan Is Caused by Solid Stress and Not Interstitial Fluid Pressure
Vikash P. Chauhan et al.
CANCER CELL (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
Mara H. Sherman et al.
CELL (2014)
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential
Cecilia S. Leung et al.
NATURE COMMUNICATIONS (2014)
Deletion of STK40 Protein in Mice Causes Respiratory Failure and Death at Birth
Hongyao Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations
Nikola Wenta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
Jizhong Liu et al.
BLOOD (2007)
IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain
RJ Bodnar et al.
CIRCULATION RESEARCH (2006)
Desmoplastic reaction in pancreatic cancer - Role of pancreatic stellate cells
MV Apte et al.
PANCREAS (2004)